AG
TMCI icon

Algert Global’s Treace Medical Concepts TMCI Stock Holding History

Algert Global’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-32,880
Closed -$193K – 1341
2025
Q2 		$193K Buy
+32,880
New +$214K ﹤0.01% 1094
2024
Q4 		– Sell
-150,991
Closed -$876K – 1337
2024
Q3 		$876K Sell
150,991
-11,545
-7% -$74.2K 0.02% 777
2024
Q2 		$1.08M Buy
162,536
+104,236
+179% +$842K 0.04% 663
2024
Q1 		$761K Buy
58,300
+39,170
+205% +$522K 0.03% 685
2023
Q4 		$244K Buy
+19,130
New +$193K 0.01% 984
2023
Q3 		– Sell
-65,894
Closed -$1.69M – 1253
2023
Q2 		$1.69M Buy
65,894
+31,500
+92% +$813K 0.07% 452
2023
Q1 		$866K Buy
34,394
+2,142
+7% +$50.3K 0.04% 686
2022
Q4 		$741K Buy
32,252
+2,940
+10% +$67.7K 0.04% 687
2022
Q3 		$647K Buy
29,312
+17,875
+156% +$346K 0.04% 723
2022
Q2 		$164K Buy
+11,437
New +$193K 0.01% 1053

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Algert Global's TMCI Position: Q3 2025 in Review

Algert Global sold out of Treace Medical Concepts (TMCI) in Q3 2025, closing a stake of 32,880 shares — an estimated $193K sold.

Algert Global first reported a position in TMCI in Q2 2022 and held it in 10 quarters. The position peaked at $1.69M in Q2 2023. 119 funds tracked by Wall St. Rank hold TMCI as of Q3 2025.

  • Algert Global reported no remaining Treace Medical Concepts position as of Q3 2025 after selling out during the quarter.
  • Algert Global sold 32,880 Treace Medical Concepts shares in Q3 2025, an estimated $193K.
  • Algert Global first reported a position in Treace Medical Concepts in Q2 2022 and held it in 10 quarters.
  • Algert Global's Treace Medical Concepts position peaked at $1.69M in Q2 2023.
  • 119 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2025.

Based on Algert Global's 13F filing for Q3 2025, filed 14 Nov 2025.